Showing 551–560 of 1051 results.
Halting drug-makers' tax inversions would undercut the practice more broadly
Summary
Digital healthcare could be a big business. However, its uptake is likely to be slow, as it deals with sensitive issues
Summary
Shifting demographics, and a new conception of aging, may stimulate new businesses
Summary
'Superbugs' present a growing threat, but are receiving little attention
Summary
The deal will create long-term opportunities for Ecuadorian exporters, but full details are yet to be concluded.
Summary
Congress will not act on 'inversions' tax manoeuvre, but the issue will be exploited politically by Democrats
Summary
Pharmaceutical giant Pfizer ended the pursuit of its competitor AstraZeneca on May 26, after a...
Summary
AstraZeneca today rejected an offer from Pfizer which would have created the world's largest...
Summary
President Barack Obama will visit Malaysia tomorrow and seek to address outstanding issues in the...
Summary
The pharmaceutical company Zogenix yesterday filed suit to halt Massachusetts Governor Deval...
Summary